The American Hospital Association is partnering with Epic on the Safer Births Postpartum Hemorrhage Collaborative, a ...

Looking for broad exposure to the Healthcare - Pharma segment of the equity market? You should consider the VanEck Pharmaceutical ETF (PPH), a passively managed exchange traded fund launched on ...

VanEck Pharmaceutical ETF (NYSEARCA:PPH) exists to give investors broad exposure to the global pharmaceutical industry ...

Eli Lilly is a mega-cap stock in the Health Care sector that has performed well in 2023, and it's the top holding in the VanEck Pharmaceutical ETF. I have a buy rating on the low-cost and style & ...

VanEck Pharmaceutical ETF offers focused exposure to large-cap pharmaceutical companies, benefiting from strong long-term demographic and innovation trends. PPH's high concentration in top holdings ...

Below is Validea's ETF fundamental report for VanEck Pharmaceutical ETF (PPH). The report looks at PPH's exposure to the major investing factors including value, quality, momentum and low volatility.

As if giving birth isn’t difficult enough, about 14 million women each year lose a significant amount of blood within 24 hours of delivery — a condition called postpartum hemorrhage (PPH). It’s more ...

“PPH requests appear to have been filed for less than 1% of U.S. applications. Why are applicants foregoing the program? While the program does not require payment of a fee per se, the author proposes ...

Big pharma stocks, as measured by the VanEck Pharmaceutical ETF (PPH), plunged Monday morning then recovered in afternoon trading as investors reacted to mixed messages about President Donald Trump’s ...